2026-04-25T17:26:25Z https://www.pub.unibl.org/oai

oai:pub.unibl.org:39950 2026-03-26T04:43:22Z

Efficacy and safety of bevacizumab in combination with irinotecan and capecitabine in first-line treatment of metastatic colorectal carcinoma /unibl/author/Saša Jungić https://www.unibl.org/sr-lat/fis/zaposlen/3255-biljana-tubic /unibl/author/Radoslav Gajanin /unibl/author/Zdenka Gojković /unibl/author/Ivanka Rakita 2017-06 Academic Article text 255 249 /unibl/sci/idNaucniRad:13156 616-006::616.348/.351-006-085 https://dx.doi.org/10.2298/VSP150513173J VOJNOSANITETSKI PREGLED 0042-8450 VOJNOSANITETSKI PREGLED 0042-8450 http://www.doiserbia.nb.rs/img/doi/0042-8450/2016%20OnLine-First/0042-84501600173J.pdf S. Jungić, B. Tubić, R. Gajanin, Z. Gojković, I. Rakita, Efficacy and safety of bevacizumab in combination with irinotecan and capecitabine in first-line treatment of metastatic colorectal carcinoma, VOJNOSANITETSKI PREGLED, Vol. 3, No. 74, pp. 249 - 255, Jun, 2017 https://www.pub.unibl.org/s/cir/item/39950